KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,620,550 | -21.9% | 323,578 | -36.7% | 0.01% | -20.0% |
| Q2 2023 | $7,195,190 | +64.0% | 511,022 | +25.3% | 0.02% | +50.0% |
| Q1 2023 | $4,387,519 | +102.0% | 407,762 | +181.2% | 0.01% | +100.0% |
| Q4 2022 | $2,172,325 | +698.6% | 145,015 | +842.3% | 0.01% | – |
| Q4 2020 | $272,000 | -2.9% | 15,390 | -15.7% | 0.00% | – |
| Q3 2020 | $280,000 | -2.1% | 18,258 | +62.4% | 0.00% | – |
| Q2 2020 | $286,000 | – | 11,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |